Nationwide Fund Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
HM
Nationwide Fund Advisors's HAE Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of Haemonetics (HAE) in Q4 2017, closing a stake of 34,155 shares — an estimated $1.53M sold.
Nationwide Fund Advisors first reported a position in HAE in Q2 2013 and held it in 18 quarters. The position peaked at $6.91M in Q4 2013. 246 funds tracked by Wall St. Rank hold HAE as of Q4 2017.
- Nationwide Fund Advisors reported no remaining Haemonetics position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 34,155 Haemonetics shares in Q4 2017, an estimated $1.53M.
- Nationwide Fund Advisors first reported a position in Haemonetics in Q2 2013 and held it in 18 quarters.
- Nationwide Fund Advisors's Haemonetics position peaked at $6.91M in Q4 2013.
- 246 funds tracked by Wall St. Rank held Haemonetics as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.